Evaluation Of Complicated Living Grief In Head And Neck Cancer Patients And Survivors
Posted Date: Feb 15, 2022
- Investigator: Rachael Nolan
- Specialties: Breast Cancer, Cancer, Cervical Cancer, Colorectal Cancer, Gynecologic Oncology, Head and Neck Cancer, Lung Cancer, Oncology, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Radiation Oncology, Skin Cancer, Surgical Oncology, Thyroid Cancer
- Type of Study: Observational/Survey
Patients with Head and neck cancer (HNC) experience significant morbidity and mortality. In addition to significant physical pain and disability, HNC is associated with increased rates of depression, anxiety, and psychosocial stress. It has been suggested that HNC patients can experience complicated living grief associated with their disease, loss of functional status, and changing societal roles. There are many clinically validated tools available to assess for the presence of complicated grief; however, none of these tools are specifically developed to look at living grief, and none have been validated to screen for complicated living grief in HNC patients. This is a prospective study of a novel complicated grief questionnaire (developed under IRB #2020-0762 UCCC-HN-20-02) with patients with head and neck cancer to determine the prevalence of complicated living grief within our sample population and to validate this tool for use within additional cancer populations.
Criteria:
Adults At Least 18 Years Old, Who Are Able To Read/Write In English Are Eligible. The Adults Must Have Received A Cancer Diagnosis (Any Type), And Will Be Receiving Or Have Received Treatment With Surgery, Radiation, Chemotherapy, And/Or Other Therapy (E.G., Immunotherapy, Hormonal Etc.…) For Their Cancer .
Keywords:
Complicated Grief, Cancer, Living Grief
For More Information:
Alexander Karabachev
(513) 213-3203
alexander.karabachev@med.uvm.edu